These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20692500)

  • 1. TCS in monogenic forms of Parkinson's disease.
    Brockmann K; Hagenah J
    Int Rev Neurobiol; 2010; 90():157-64. PubMed ID: 20692500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
    Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
    J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
    Walter U
    J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Parkinson's disease--transcranial sonography in relation to MRI.
    Niehaus L; Boelmans K
    Int Rev Neurobiol; 2010; 90():63-79. PubMed ID: 20692494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
    Ruprecht-Dörfler P; Berg D; Tucha O; Benz P; Meier-Meitinger M; Alders GL; Lange KW; Becker G
    Neuroimage; 2003 Feb; 18(2):416-22. PubMed ID: 12595195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
    Walter U
    Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial sonography in relation to SPECT and MIBG.
    Kajimoto Y; Miwa H; Kondo T
    Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
    Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
    Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
    Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
    Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
    Berg D
    J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles.
    Hagenah JM; König IR; Becker B; Hilker R; Kasten M; Hedrich K; Pramstaller PP; Klein C; Seidel G
    J Neurol; 2007 Oct; 254(10):1407-13. PubMed ID: 17934880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of transcranial sonography signal changes in the human substantia nigra.
    Double KL; Todd G; Duma SR
    Int Rev Neurobiol; 2010; 90():107-20. PubMed ID: 20692497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial sonography in the discrimination of Parkinson's disease versus vascular parkinsonism.
    Venegas-Francke P
    Int Rev Neurobiol; 2010; 90():147-56. PubMed ID: 20692499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
    Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
    Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial sonography in patients with Parkinson's disease with glucocerebrosidase mutations.
    Kresojević N; Mijajlović M; Perić S; Pavlović A; Svetel M; Janković M; Dobričić V; Novaković I; Lakočević MB; Klein C; Kostić VS
    Parkinsonism Relat Disord; 2013 Apr; 19(4):431-5. PubMed ID: 23332636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial ultrasound as a risk marker for Parkinson's disease.
    Berg D
    Mov Disord; 2009; 24 Suppl 2():S677-83. PubMed ID: 19877199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transcranial sonography-magnetic resonance fusion imaging in Wilson's and early-onset Parkinson's diseases.
    Mašková J; Školoudík D; Burgetová A; Fiala O; Brůha R; Záhoráková D; Serranová T; Slovák M; Ulmanová O; Růžička E; Dušek P
    Parkinsonism Relat Disord; 2016 Jul; 28():87-93. PubMed ID: 27147115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing Parkinson's disease and essential tremor with transcranial sonography.
    Budisic M; Trkanjec Z; Bosnjak J; Lovrencic-Huzjan A; Vukovic V; Demarin V
    Acta Neurol Scand; 2009 Jan; 119(1):17-21. PubMed ID: 18549415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.